Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6640
- TODAY'S CHANGE (%)-0.0185 (-2.7106%)
- Bid / Lots0.6512/ 67
- Ask / Lots0.6999/ 20
- Open / Previous Close0.6850 / 0.6825
- Day Range
- 52 Week Range
- Volume304,153
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 1619 | 0.685 |
| 09:34 ET | 500 | 0.6899 |
| 09:36 ET | 300 | 0.6949 |
| 09:41 ET | 180 | 0.69 |
| 09:43 ET | 636 | 0.6942 |
| 09:45 ET | 1600 | 0.69425 |
| 09:48 ET | 100 | 0.69425 |
| 09:50 ET | 200 | 0.69425 |
| 09:52 ET | 100 | 0.69425 |
| 09:54 ET | 100 | 0.69425 |
| 09:56 ET | 100 | 0.69 |
| 09:57 ET | 100 | 0.69 |
| 10:01 ET | 2754 | 0.6853 |
| 10:03 ET | 300 | 0.6891 |
| 10:06 ET | 8968 | 0.6766 |
| 10:08 ET | 2834 | 0.6746 |
| 10:10 ET | 300 | 0.6748 |
| 10:12 ET | 1100 | 0.675 |
| 10:15 ET | 228 | 0.675 |
| 10:19 ET | 4102 | 0.675 |
| 10:24 ET | 11300 | 0.6766 |
| 10:26 ET | 500 | 0.6789 |
| 10:28 ET | 2296 | 0.678 |
| 10:32 ET | 300 | 0.6768 |
| 10:33 ET | 180 | 0.6755 |
| 10:35 ET | 100 | 0.675 |
| 10:37 ET | 6200 | 0.6729 |
| 10:39 ET | 100 | 0.67435 |
| 10:51 ET | 100 | 0.6757 |
| 10:53 ET | 200 | 0.6725 |
| 10:55 ET | 100 | 0.671 |
| 11:00 ET | 100 | 0.67335 |
| 11:02 ET | 135 | 0.6741 |
| 11:04 ET | 100 | 0.6718 |
| 11:08 ET | 290 | 0.6701 |
| 11:09 ET | 8970 | 0.6694 |
| 11:11 ET | 350 | 0.670469 |
| 11:13 ET | 100 | 0.6707 |
| 11:15 ET | 400 | 0.6709 |
| 11:18 ET | 100 | 0.6693 |
| 11:20 ET | 100 | 0.6691 |
| 11:24 ET | 6144 | 0.6675 |
| 11:26 ET | 350 | 0.6658 |
| 11:27 ET | 100 | 0.6658 |
| 11:29 ET | 100 | 0.6675 |
| 11:31 ET | 120 | 0.663 |
| 11:42 ET | 100 | 0.6636 |
| 11:45 ET | 111 | 0.6643 |
| 11:47 ET | 2565 | 0.6632 |
| 11:49 ET | 750 | 0.6601 |
| 11:51 ET | 262 | 0.6616 |
| 11:58 ET | 100 | 0.6632 |
| 12:02 ET | 100 | 0.6632 |
| 12:14 ET | 100 | 0.6615 |
| 12:16 ET | 100 | 0.6629 |
| 12:18 ET | 500 | 0.662799 |
| 12:21 ET | 100 | 0.6615 |
| 12:25 ET | 1400 | 0.6602 |
| 12:27 ET | 100 | 0.6616 |
| 12:30 ET | 1000 | 0.6603 |
| 12:32 ET | 100 | 0.6603 |
| 12:34 ET | 901 | 0.6601 |
| 12:36 ET | 100 | 0.6601 |
| 12:38 ET | 145 | 0.66 |
| 12:39 ET | 100 | 0.66 |
| 12:41 ET | 100 | 0.6603 |
| 12:43 ET | 450 | 0.6602 |
| 12:48 ET | 100 | 0.6603 |
| 12:50 ET | 1022 | 0.6603 |
| 12:52 ET | 1738 | 0.6602 |
| 12:54 ET | 27333 | 0.6564 |
| 12:56 ET | 1475 | 0.655 |
| 12:59 ET | 200 | 0.66 |
| 01:01 ET | 100 | 0.6565 |
| 01:03 ET | 716 | 0.6563 |
| 01:06 ET | 100 | 0.6563 |
| 01:08 ET | 823 | 0.6573 |
| 01:10 ET | 1377 | 0.655 |
| 01:14 ET | 100 | 0.6573 |
| 01:15 ET | 100 | 0.655 |
| 01:19 ET | 302 | 0.655 |
| 01:21 ET | 500 | 0.6581 |
| 01:24 ET | 11165 | 0.6603 |
| 01:28 ET | 100 | 0.6608 |
| 01:32 ET | 100 | 0.6608 |
| 01:35 ET | 8100 | 0.6588 |
| 01:37 ET | 3263 | 0.6671 |
| 01:39 ET | 1108 | 0.6671 |
| 01:48 ET | 100 | 0.6674 |
| 01:50 ET | 200 | 0.6669 |
| 01:51 ET | 3200 | 0.6671 |
| 01:57 ET | 100 | 0.667 |
| 02:04 ET | 100 | 0.66695 |
| 02:09 ET | 216 | 0.666 |
| 02:11 ET | 100 | 0.666 |
| 02:15 ET | 100 | 0.666 |
| 02:18 ET | 200 | 0.6678 |
| 02:22 ET | 516 | 0.666 |
| 02:24 ET | 600 | 0.666 |
| 02:26 ET | 1500 | 0.6657 |
| 02:27 ET | 1635 | 0.6647 |
| 02:29 ET | 728 | 0.66545 |
| 02:31 ET | 398 | 0.6655 |
| 02:38 ET | 300 | 0.6627 |
| 02:42 ET | 100 | 0.6627 |
| 02:44 ET | 922 | 0.6612 |
| 02:45 ET | 204 | 0.6615 |
| 02:47 ET | 100 | 0.6615 |
| 02:49 ET | 379 | 0.66 |
| 02:54 ET | 200 | 0.66 |
| 02:56 ET | 377 | 0.6631 |
| 02:58 ET | 100 | 0.66 |
| 03:02 ET | 100 | 0.6631 |
| 03:03 ET | 1704 | 0.6601 |
| 03:09 ET | 2464 | 0.6601 |
| 03:12 ET | 5396 | 0.6587 |
| 03:14 ET | 200 | 0.6587 |
| 03:18 ET | 200 | 0.6593 |
| 03:20 ET | 1713 | 0.6587 |
| 03:21 ET | 325 | 0.6579 |
| 03:25 ET | 14774 | 0.6573 |
| 03:27 ET | 4514 | 0.6562 |
| 03:30 ET | 200 | 0.6573 |
| 03:32 ET | 3054 | 0.6573 |
| 03:36 ET | 500 | 0.658 |
| 03:38 ET | 800 | 0.657959 |
| 03:39 ET | 4648 | 0.6575 |
| 03:41 ET | 2168 | 0.6599 |
| 03:43 ET | 100 | 0.6599 |
| 03:48 ET | 1600 | 0.66 |
| 03:50 ET | 3988 | 0.66 |
| 03:54 ET | 100 | 0.6671 |
| 03:56 ET | 322 | 0.6639 |
| 03:57 ET | 400 | 0.6609 |
| 03:59 ET | 37865 | 0.664 |
Jun 7, 2024
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), from 5:59PM ET on Friday Jun 07, 2024 by Dow Jones
5:59PM ET on Friday Jun 07, 2024 by Dow Jones
May 29, 2024
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 49.7M | -0.5x | --- |
DURECT Corp | 51.2M | -2.1x | --- |
LAVA Therapeutics NV | 61.5M | -2.0x | --- |
Kronos Bio Inc | 64.9M | -0.5x | --- |
BioLine RX Ltd | 55.9M | -0.8x | --- |
Curis Inc | 47.9M | -0.9x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Chief Executive Officer, Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Chief Business Officer
- Nick Mordwinkin
- Chief Legal Officer
- Mark Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $49.7M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 72.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.29 |
EPS | $-1.40 |
Book Value | $2.58 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,591.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
